Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Oral Health
Published in: BMC Oral Health 1/2015

Open Access 01-12-2015 | Research article

S100, bcl2 and myeloperoxid protein expirations during periodontal inflammation

Authors: Yevhen Kuzenko, Anatoliy Romanyuk, Antonina Politun, Ludmila Karpenko

Published in: BMC Oral Health | Issue 1/2015

Login to get access

Abstract

Background

Periodontal inflammation is characterized by injuries in collagen, epithelial, bone tissues. The hypotheses to be tested were relationship between the s100, bcl2 and myeloperoxidase in gingival tissues (MPO does affect the level of s100, bcl2). The object of this study was to investigate of s100 expression, bcl2 expression and myeloperoxidase expression in periodontal inflammation.

Methods

27 patients (giant-cell epulis) and 30 patients (acute and chronic inflammations) were included in the study for s100 expression, bcl2 expression and myeloperoxidase expression by immunohistochemistry and hematoxylin - eosin.

Results

Giant-cells in epulis positivity for myeloperoxidase has been observed in 100 % However, only 75.31 % of giant-cells were positive for bcl2 expression. Acute 98.2 %, and chronic 89.28 % inflammation was a significant positive for myeloperoxidase. The immunohistochemical findings of s100, bcl 2 and myeloperoxidase in epithelial layers have showed the result of 100 %, 82,2 %, 100 % positive cells in acute and 100 %, 78.25 %, 100 % in chronic process of inflammation respectively.

Conclusion

The results indicate that the pathogenesis of periodontal inflammation might involve inhibition of cell death, through the overexpression of bcl-2, due to identifying factors myeloperoxidase (result in the DNA damage by the product of catalysis). The highest levels of s100 activity have been found at sites with chronic inflammation.
Literature
1.
Carvalho-Filho PC, Trindade SC, Olczak T, Sampaio GP, Oliveira-Neto MG, Santos HA, et al. Porphyromonas gingivalis HmuY stimulates expression of Bcl2 and Fas by human CD3+ T cells. BMC Microbiol. 2013;13:206.CrossRefPubMedPubMedCentral
2.
McGhee ML, Ogawa T, Pitts AM, Moldoveanu Z, Mestecky J, McGhee JR, et al. Cellular analysis of functional mononuclear cells from chronically inflammed gingival tissue. Reg Immunol. 1989;2:103–7.PubMed
3.
Baelum V, Lopez R. Periodontal epidemiology: towards social science or molecular biology? Community Dent Oral Epidemiol. 2004;32(4):239–49.CrossRefPubMed
4.
Cao CF, Smith QT. Crevicular fluid myeloperoxidase at healthy, gingivitis and periodontitis sites. J Clin Periodontol. 1989;16:17–20.CrossRefPubMed
5.
6.
Miyasaki KT, Nemirovskiy E. Myeloperoxidase isoform activities released by human neutrophils in response to dental and periodontal bacteria. Oral Microbiol Immunol. 1997;12:27–32.CrossRefPubMed
7.
8.
Takane M, Sugano N, Iwasaki H, Iwano Y, Shimizu N, Ito K. New biomarker evidence of oxidative DNA damage in whole saliva from clinically healthy and periodontally diseased individuals. J Periodontol. 2002;73(5):551–4.CrossRefPubMed
9.
Gamonal J, Bascones A, Acevedo A, Blanco E, Silva A. Apoptosis in chronic adult periodontitis anaiyzed by in situ DNA breaks, electron microscopy, and immunohistochemistry. Pariodontol. 2001;72:517–25.CrossRef
10.
Peter ME, Budd RC, Desbarats J, Hedrick SM, Hueber AO, Newell MK, et al. The CD95 Receptor: Apoptosis Revisited. Cell. 2000;129(4):427–50.
11.
12.
Volz A, Korge BP, Compton JG, Ziegler A, Steinert PM, Mischke D. Physical mapping of a functional cluster of epidermal differentiation genes on chromosome 1q21. Genomics. 1994;18(1):92–9.CrossRef
13.
Lane D, Lu X, Hupp T, Hall P. The role of p53 protein in the apoptotic response. Philos Trans R Soc Lond Scr B. 1994;345:277–80.CrossRef
14.
Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988;335(6189):440–2.CrossRefPubMed
15.
Becerik S, Afacan B, Oztürk VÖ, Atmaca H, Emingil G. Gingival crevicular fluid calprotectin, osteocalcin and cross-linked N-terminal telopeptid levels in health and different periodontal diseases. Dis Markers. 2011;31:343–52.CrossRefPubMedPubMedCentral
16.
17.
Meisel P, Krause T, Cascorbi I, Schroeder W, Herrmann F, John U. Gender and smoking-related risk reduction of periodontal disease with variant myeloperoxidase alleles. Genes Immun. 2002;3:102–6.CrossRefPubMed
18.
Urban CF, Ermert D, Schmid M, Abu-Abed U, Goosmann C, Nacken W, et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog. 2009;5(10), e1000639.CrossRefPubMedPubMedCentral
19.
Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007;176(2):231–41.CrossRefPubMedPubMedCentral
20.
Pradeep AR, Martande SS, Singh SP, Suke DK, Raju AP, Naik SB, et al. Correlation of human S100A12 (EN-RAGE) and high-sensitivity C-reactive protein as gingival crevicular fluid and serum markers of inflammation in chronic periodontitis and type 2 diabetes. Inflamm Res. 2014;63:317–23.CrossRefPubMed
21.
Bascones A, Gamonal J, Gomez M, Silva A, Gonzalez MA. New knowledge of the pathogenesis of periodontal disease. Quintessence Int. 2004;35:706–16.PubMed
22.
23.
Gamonal J, Bascones A, Acevedo A, Blanco E, Silva A. Apoptosis in chronic adult periodontitis analyzed by in situ DNA breaks, electron microscopy, and immunohistochemistry. J Periodontol. 2001;72:517–25.CrossRefPubMed
24.
Pandilova M. Comparative analysis of apoptotic cell death during periodontal disease. Doctors Dissertation. 2003;78:258–356.
25.
Ellis SD, Tucci MA, Serio FG, Johnson RB. Factors for progression of periodontal diseases. J Oral Pathol Med. 1998;27:101–5.CrossRefPubMed
26.
Bulut S, Ozdemir BH, Alaaddinoĝlu EE, Oduncuoĝlu FB, Bulut OE, Demirhan B. Effect of Cyclosporin A on Apoptosis and Expression of p53 and bcl-2 Proteins in the Gingiva of Renal Transplant Patients. J Periodontol. 2005;76:691–5.CrossRefPubMed
27.
Hayashi N, Kido J, Kido R, Wada C, Kataoka M, Shinohara Y, et al. Regulation of calprotectin expression by interleukin-1alpha and tansforming growth factor-beta in human gingival keratinocytes. J Periodontal Res. 2007;42:1–7.CrossRefPubMed
28.
Echelard S, Hoyaux D, Hermans M, Daelemans P, Roth J, Philippart P, et al. S100A8 and S100A9 calcium-binding proteins: localization within normal and cyclosporin A-induced overgrowth gingiva. Connect Tissue Res. 2002;43:419–24.CrossRefPubMed
29.
Saito K, Mori S, Tanda N, Sakamoto S. Immunolocalization of c-Myc and bcl-2 proto-oncogene productrs in gingival hyperplasia induced by nifedipine and phenytoin. J Periodontol. 2000;71:44–9.CrossRefPubMed
30.
Mueller A, Schafer BW, Ferrari S, Weibel M, Makek M, Hochli M, et al. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity. J Biol Chem. 2005;280:29186–93.CrossRefPubMed
31.
Ryan JJ, Prochownik E, Gottlieb CA. C-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad SciUSA. 1994;91:5878–82.CrossRef
32.
Rugtveit J, Nilsen EM, Bakka A, Carlsen H, Brandtzaeg P, Scott H. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology. 1997;112:1493–505.CrossRefPubMed
33.
Lugering N, Stoll R, Kucharzik T, Schmid KW, Rohlmann G, Burmeister G, et al. Immunohistochemical distribution and serum levels of the Ca(2)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion. 1995;56:406–14.CrossRefPubMed
34.
Seeliger S, Vogl T, Engels I, Schröder JM, Sorg C, Sunderkötter C, et al. Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases. Am J Pathology. 2003;163:947–56.CrossRef
35.
Foell D, Ichida F, Vogl T, Yu X, Chen R, Miyawaki T, et al. S100A12 (EN-RAGE) in monitoring Kawasaki disease. Lancet. 2003;361:1270–2.CrossRefPubMed
Metadata
Title
S100, bcl2 and myeloperoxid protein expirations during periodontal inflammation
Authors
Yevhen Kuzenko
Anatoliy Romanyuk
Antonina Politun
Ludmila Karpenko
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2015
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-015-0077-8

Other articles of this Issue 1/2015

BMC Oral Health 1/2015 Go to the issue

Research article

Eating disorders - knowledge, attitudes, management and clinical experience of Norwegian dentists

Research article

Stability of simultaneously placed dental implants with autologous bone grafts harvested from the iliac crest or intraoral jaw bone

Research article

Change of periodontal inflammatory indicators through a 4-week weight control intervention including caloric restriction and exercise training in young Koreans: a pilot study

Study protocol

The midwifery initiated oral health-dental service protocol: an intervention to improve oral health outcomes for pregnant women

Research article

Severe early childhood caries and social determinants in three-year-old children from Northern Thailand: a birth cohort study

Research article

Knowledge about permanent tooth avulsion and its management among dentists in Riyadh, Saudi Arabia